Exec Chat: Manus Neurodynamica Will Augment Pharmaceutical Companies’ Drug Trials
Simple-to-use devices capable of recording a plethora of data could be used to speed up drug trials and improve drug delivery, according to Rutger Zietsma, of Manus Neurodynamica.
You may also be interested in...
As wearable technologies and other devices become capable of recording large amounts of data for use in clinical trials, industry experts are asking why pharma has been slow to maximize the opportunity in product development.
Manus Neurodynamica intends to launch a pen, which provides early and accurate diagnosis of Parkinson’s disease, to the UK and Benelux markets and has £5m in funding to date.
Inivata will remain a separate liquid biopsy division alongside NeoGenomics’ growing clinical, pharma and informatics divisions.